Identification of Pathogenic Missense Mutations in the CHRNA5 Gene: A Computational Approach

Mahalakshmi Kumaraguru1, Leelavathi L1, Vijayashree J Priyadharsini2

  • 1Public Health Dentistry, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Cureus
|November 29, 2023
PubMed

Insights

Genetic analysis identified harmful mutations in the CHRNA5 gene, potentially linking them to smoking behaviors and nicotine dependence. This research may guide future medication development for smoking-related disorders.

Area of Science:

  • Genetics
  • Pharmacology
  • Computational Biology

Background:

  • The CHRNA5/A3/B4 gene locus is implicated in nicotine dependence and smoking-related disorders.
  • Investigating genetic variations offers potential for novel medication development.
  • Understanding functional mutations is key to elucidating disease mechanisms.

Purpose of the Study:

  • To identify and analyze functional missense mutations within the human CHRNA5 gene.
  • To computationally predict the pathogenicity of CHRNA5 missense variants.
  • To explore the association between CHRNA5 mutations and smoking-related traits.

Main Methods:

  • Utilized the Ensembl database to collect human CHRNA5 missense variants.
  • Employed multiple computational tools including SIFT, PolyPhen, PROVEAN, I-Mutant, and MutPred.
  • Assessed the functional impact and pathogenicity of identified variants.

Main Results:

  • Analyzed 161 missense variants in the CHRNA5 gene.
  • Identified 94 highly pathogenic variants.
  • Classified 20 variants as pathogenic and 4 as non-pathogenic.

Conclusions:

  • Computational analysis revealed significant harmful mutations in the CHRNA5 gene.
  • These identified mutations are potentially associated with smoking-related traits.
  • Findings may contribute to understanding the genetic basis of nicotine dependence.